Analysis | Metabolite Name | Measured Value | Units | Construct |
---|---|---|---|---|
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 3588.323556 | Peak area normalized | GCKR_52621 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 3725.09557 | Peak area normalized | PNPLA3_50053 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 3843.282644 | Peak area normalized | GCKR_52621 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 4672.933029 | Peak area normalized | TM6SF2_382426 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 4748.699177 | Peak area normalized | PPP1R3B_2640-25-9-16 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 4977.68451 | Peak area normalized | PPP1R3B_2640-25-9-16 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 5316.348601 | Peak area normalized | GCKR_52621 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 6310.697506 | Peak area normalized | PNPLA3_50053 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 7466.25551 | Peak area normalized | PNPLA3_50053 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 12106.87343 | Peak area normalized | PNPLA3(I148M) |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 12923.75363 | Peak area normalized | Vector-25-9-16 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 14967.76187 | Peak area normalized | PPP1R3B_2640-25-9-16 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 15083.74863 | Peak area normalized | PNPLA3(I148M) |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 15289.97672 | Peak area normalized | NT-25-9-16 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 15874.85712 | Peak area normalized | TM6SF2_382426 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 16117.66864 | Peak area normalized | NT-25-9-16 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 18136.67182 | Peak area normalized | NT-25-9-16 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 21455.15597 | Peak area normalized | Vector-25-9-16 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 21904.01175 | Peak area normalized | PNPLA3(I148M) |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 26425.79009 | Peak area normalized | PNPLA3(WT) |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 26438.34112 | Peak area normalized | TM6SF2_382426 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 34186.18515 | Peak area normalized | PNPLA3(WT) |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 42035.84385 | Peak area normalized | Vector-25-9-16 |
C18 NEGATIVE ION MODE | N-(eicosanoyl)-sphinganine; [M-H]-@8.16 | 45860.41163 | Peak area normalized | PNPLA3(WT) |